-
The two major pharmaceutical companies have reached a strategic cooperation, opening up new attempts and new opportunities for pharmaceutical cooperation models
Time of Update: 2022-08-30
Kunpharm Commercial will firmly consolidate the basic management, accelerate the three-year strategic goal of pure sales transformation, firmly establish the value chosen by upstream industrial enterprises, share resources with Lunan Pharmaceutical, and achieve a new leap in cooperation .
-
This pharmaceutical company joins hands with scientific research institutions to jointly research and develop new Chinese medicines
Time of Update: 2022-08-30
At that time, Panlong Pharmaceutical had signed a strategic cooperation agreement with Shaanxi Institute of Traditional Chinese Medicine, and planned to jointly develop "Qingwen Hufei Granules" with the platform of "Centralized Distribution Center for In-Hospital Preparations" through this convertible bond fundraising project.
-
Another pharmaceutical company achieved double growth in revenue and net profit in the first half of the year!
Time of Update: 2022-08-30
According to the semi-annual report, Tebao Bio is an innovative biopharmaceutical enterprise mainly engaged in the research and development, production and sales of recombinant proteins and their long-acting modified drugs .
-
Ruike Biologics Announces the Latest Progress of Phase III Clinical Development of Recombinant Nine-valent HPV Vaccine
Time of Update: 2022-08-20
The phase III clinical trial of REC603 in China consists of three parts: the main efficacy trial, the immune bridging trial in small age groups, and the immunogenicity comparison trial with Gardasil?
-
For the sake of livelihood, this AI pharmaceutical company announced layoffs!
Time of Update: 2022-08-19
It is reported that in addition to the announcement of layoffs by AbSci, in July, the first molecule DSP-1181 designed by AI to enter the clinic has also been "abandoned" by pharmaceutical companies because it did not meet expectations .
-
The termination of development of innovative drugs has become the norm, and the pharmaceutical company has given up a new drug cooperation
Time of Update: 2022-08-19
"When choosing a cooperation project, we will also comprehensively evaluate the scientific and technological strength of the invested company to avoid the risk of clinical trial failure as much as possible .
-
Heart experts call for early detection, early treatment, and improved access to innovative drugs for atrial fibrillation
Time of Update: 2022-08-19
If insufficient attention is paid, atrial fibrillation will further develop and lead to serious complications, the most common being stroke caused by thrombosis, which has a high disability rate and is life-threatening in severe cases; in addition, heart failure and systemic Embolic events reduce the quality of life of patients and carry a large medical burden .
-
With the sword pointing at 1 billion varieties, NHU is waiting for the turning point in the second half of the year
Time of Update: 2022-08-19
The report shows that in the first half of the year, the company's operating income increased by 7.
The report shows that in the first half of the year, the company's operating income increased by 7.
-
The performance of this pharmaceutical company has skyrocketed, and its net profit in the first half of 2022 will increase by more than 20,000%
Time of Update: 2022-08-15
. As for the reasons for the changes in performance in the first half of this year, Jiu'an Medical explained in the announcement that the company's iHealth kit products have obtained the FDA EUA authorization in the United States, and the company's own brand "iHealth" is used through the website of the US subsidiary and Amazon's US e-commerce platform.
-
The two vice presidents of Guang Yuyuan resigned!
Time of Update: 2022-08-15
. The Shanghai Stock Exchange pointed out in the question that Guangyuyuan's sales expenses in 2021 will be 782 million yuan, an increase of 546 million yuan compared with the 2021 semi-annual report, and a year-on-year increase of 35.
-
Blockbuster drugs face patent cliff, and this multinational pharmaceutical company is accelerating acquisitions
Time of Update: 2022-08-15
[Pharmaceutical News] Recently, Merck and Orion announced that they have reached a global research and development cooperation agreement to jointly develop Orion's investigational therapy ODM-208 and other drugs targeting cytochrome P450 11A1 (CYP11A1), which is a steroid synthesis.
-
Focusing on innovative drugs and medical beauty, the pharmaceutical company plans to gradually divest its generic drug business
Time of Update: 2022-08-15
A shrinking market for well-defined drugs and high-priced generics is a foregone conclusion In the 2021 annual report, Sihuan Pharmaceutical believes that the current generic drug business has increased by 18.
-
Nanjing Special Medical Food Exchange Conference Xinlai Group escorts special medical food!
Time of Update: 2022-08-15
Kinglai Group - Escort for Special Medical Food Nanjing·Special Medical Food Experience Sharing Conference 2022 Conference on Technical Key Points of Registration and Review of Formula Foods for Spec
-
Bailinke's disposable bags passed the DMF filing to help Chinese biopharmaceutical companies set sail to the sea
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] Recently, the single-use multi-layer co-extrusion bag produced by Bailinke has passed the US Food and Drug Administration DMF filing (FDA DMF filing number: 0
-
Lu Xiangyi continued to expand the overseas "circle of friends" and sent 1,000 boxes of low-speed centrifuges to Brazil
Time of Update: 2022-08-15
The instrument of choice for small volume separations According to reports, the TD4A low-speed centrifuge that Lu Xiangyi sent to Brazil this time has the characteristics of small size, low noise, stable operation and high rotational speed accuracy.
-
Congratulations to Tianjin Bohai Xinmao for winning the "June Pharmaceutical Network's June Pharmaceutical Machine Event Enterprise Live Broadcasting Award"!
Time of Update: 2022-08-15
According to reports, Tianjin Bohai Xinmao is committed to the research and development and production of machinery in the fields of pharmaceuticals, food and chemicals, and provides high-quality pre-sales and after-sales services Tianjin Bohai Xinmao part of the live broadcast So what kind of company is this?
-
Two major pharmaceutical companies join hands to promote the commercialization of two innovative drugs in China
Time of Update: 2022-08-15
com Company News] Taking patients as the center and clinical needs as the orientation, Fosun Pharma has continuously enriched its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, licensing introduction, and deep incubation .
-
From June 1st, Lu Xiangyi will resume work and production at full speed!
Time of Update: 2022-08-15
On the morning of May 31, at a press conference on the prevention and control of the new coronary pneumonia epidemic in Shanghai, Zong Ming, deputy mayor of Shanghai, said that from June 1, Shanghai will enter the third stage, that is, to fully restore the normal production and living order in the city stage .
-
Congratulations!
Time of Update: 2022-08-15
With the improvement of the pharmaceutical market and the technical level of granulation equipment, a large number of granulation equipment companies have begun to emerge in recent years GLZ-120 intelligent automatic dry granulator Granulation has always been a very important process in the pharmaceutical industry.
-
220 million yuan!
Time of Update: 2022-08-15
[Pharmaceutical Network Corporate News] TusHoldings recently announced that the company intends to sign an Equity Transfer Agreement with two shareholders of Guangdong Xantong, Beijing Xantongyuan Pharmaceutical Technology Co.
